RT $SGMO PFE have been pushing ahead at maximum speed with a rival gene therapy SB525 that posted positive early responses
stronger data on durability could yet prevent $BMRN BioMarin from capturing and keeping market share
https://t.co/Ybd7ThDpWr

PS: $PFE presents data tomorrow